Jo‐Anne van Burik

4.2k total citations · 1 hit paper
16 papers, 3.1k citations indexed

About

Jo‐Anne van Burik is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, Jo‐Anne van Burik has authored 16 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Epidemiology and 4 papers in Small Animals. Recurrent topics in Jo‐Anne van Burik's work include Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (7 papers) and Infectious Diseases and Mycology (4 papers). Jo‐Anne van Burik is often cited by papers focused on Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (7 papers) and Infectious Diseases and Mycology (4 papers). Jo‐Anne van Burik collaborates with scholars based in United States, United Kingdom and France. Jo‐Anne van Burik's co-authors include John R. Wingard, Vicki A. Morrison, Elias Anaissie, Brahm H. Segal, Thomas J. Walsh, Thomas F. Patterson, Dimitrios P. Kontoyiannis, David A. Stevens, Kieren A. Marr and Raoul Herbrecht and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Jo‐Anne van Burik

15 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

2008 1.9k citations Thomas J. Walsh, Elias Anaissie et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Jo‐Anne van Burik

Since Specialization

Citations

This map shows the geographic impact of Jo‐Anne van Burik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo‐Anne van Burik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo‐Anne van Burik more than expected).

Fields of papers citing papers by Jo‐Anne van Burik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo‐Anne van Burik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo‐Anne van Burik. The network helps show where Jo‐Anne van Burik may publish in the future.

Co-authorship network of co-authors of Jo‐Anne van Burik

This figure shows the co-authorship network connecting the top 25 collaborators of Jo‐Anne van Burik. A scholar is included among the top collaborators of Jo‐Anne van Burik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo‐Anne van Burik. Jo‐Anne van Burik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America breakdown → 2008 ·Clinical Infectious Diseases ·Thomas J. Walsh, Elias Anaissie, David W. Denning, Raoul Herbrecht, Dimitrios P. Kontoyiannis, Kieren A. Marr, Vicki A. Morrison, Brahm H. Segal, William J. Steinbach, David A. Stevens, Jo‐Anne van Burik, John R. Wingard, Thomas F. Patterson	1944
2	Tratamiento de la Aspergilosis: Guías para la práctica clínica de la Sociedad de Enfermedades Infecciosas de los Estados Unidos de América (IDSA) 2008 ·Clinical Infectious Diseases ·Thomas J. Walsh, Elias Anaissie, David W. Denning, Raoul Herbrecht, Dimitrios P. Kontoyiannis, Kieren A. Marr, Vicki A. Morrison, Brahm H. Segal, William J. Steinbach, David A. Stevens, Jo‐Anne van Burik, John R. Wingard, (unknown)	9
3	Cat‐scratch disease relapse in a kidney transplant recipient 2006 ·Pediatric Transplantation ·Michelle N. Rheault, Jo‐Anne van Burik, Michael Mauer, Elizabeth Ingulli, Patricia Ferrieri, José Jessurun, Blanche M. Chavers	19
4	Prophylaxis Against Cytomegalovirus Infections with Oral Maribavir in Allogeneic Stem Cell Transplant Recipients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial. 2006 ·Blood ·Drew J. Winston, Jo‐Anne van Burik, Vinod Pullarkat, Genovefa A. Papanicolaou, Ravi Vij, Estil Vance, George Alangaden, Roy F. Chemaly, Finn Bo Petersen, Nelson J. Chao, Jared Klein, Kellie Sprague, (unknown), Stephen Villano, Michael Boeckh	5
5	Allogeneic Hematopoietic Stem Cell Transplantation in HIV-Positive Patients with Malignant and Non-Malignant Disorders: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR). 2006 ·Blood ·Vikas Gupta, Marcie Tomblyn, (unknown), Jill C. Thompson, (unknown), Jan Storek, Jo‐Anne van Burik, Mary Horowitz, Armand Keating	4
6	Acquired Pure Red Cell Aplasia Associated with Alemtuzumab, Mycophenolate, and Daclizumab Immunosuppression after Pancreas Transplant. 2005 ·Blood ·(unknown), (unknown), (unknown), Rainer W.G. Gruessner, Angelika C. Gruessner, David E.R. Sutherland, Barbara Bland, Robert B. Howe, Jo‐Anne van Burik, (unknown), Mark T. Reding, (unknown), Nigel S. Key	1
7	Reservoir ofCandidaalbicansinfection in a vascular bypass graft demonstrates a stable karyotype over six months 2004 ·Medical Mycology ·Paul Lephart, Patricia Ferrieri, Jo‐Anne van Burik	7
8	Transplant infections, second edition 2004 ·American Journal of Kidney Diseases ·Jo‐Anne van Burik	2
9	A Double‐Blind, Randomized, Controlled Trial of Amphotericin B Colloidal Dispersion versus Amphotericin B for Treatment of Invasive Aspergillosis in Immunocompromised Patients 2002 ·Clinical Infectious Diseases ·Raleigh A. Bowden, Pranatharthi Chandrasekar, Mary H. White, Xin Li, Larry Pietrelli, Marc Gurwith, Jo‐Anne van Burik, Michél Laverdière, Sharon Safrin, John R. Wingard	225
10	Clinical applications of non-culture based methods for the diagnosis and management of opportunistic and endemic mycoses 2000 ·Medical Mycology ·Paul E. Verweij, (unknown), Jo‐Anne van Burik, M.D. Holdom, Eduardo Dei‐Cas, (unknown), Maria José Soares Mendes‐Giannini	22
11	A Phase I-II Clinical Trial to Evaluate Removal of CD4 Cells and Partial Depletion of CD8 Cells From Donor Marrow for HLA-Mismatched Unrelated Recipients 1999 ·Blood ·Paul J. Martin, Scott D. Rowley, Claudio Anasetti, Thomas R. Chauncey, Ted Gooley, Effie W. Petersdorf, Jo‐Anne van Burik, Mary E.D. Flowers, Rainer Storb, Frederick R. Appelbaum, John A. Hansen	70
12	Determinants of Human Immunodeficiency Virus DNA and RNA Shedding in the Anal‐Rectal Canal of Homosexual Men 1998 ·The Journal of Infectious Diseases ·Nancy B. Kiviat, Cathy W. Critchlow, Stephen E. Hawes, Jane Kuypers, Christina M. Surawicz, Gary Goldbaum, Jo‐Anne van Burik, Thomas M. Lampinen, King K. Holmes	32
13	Panfungal PCR Assay for Detection of Fungal Infection in Human Blood Specimens 1998 ·Journal of Clinical Microbiology ·Jo‐Anne van Burik, David Myerson, (unknown), Raleigh A. Bowden	207
14	Reply 1998 ·The Journal of Infectious Diseases ·Anna Wald, Wendy M. Leisenring, Jo‐Anne van Burik, Raleigh A. Bowden	2
15	Nocardiosis After Bone Marrow Transplantation: A Retrospective Study 1997 ·Clinical Infectious Diseases ·Jo‐Anne van Burik, Robert C. Hackman, (unknown), John W. Hiemenz, Mary H. White, Mary E.D. Flowers, Raleigh A. Bowden	83
16	Detection and identification of fungal pathogens in blood by using molecular probes 1997 ·Journal of Clinical Microbiology ·Hermann Einsele, Holger Hebart, (unknown), Jürgen Löffler, (unknown), C A Müller, Raleigh A. Bowden, Jo‐Anne van Burik, Dan Engelhard, Lothar Kanz, Ulrike Schumacher	459

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact